Do you want to read an article? Please log in or register.
Prevention and management of amivantamab-induced dermatologic toxicities: a European expert consensus and practical algorithm
Lung, Respiratory and Thoracic Cancer
Related content
SPECIAL REPORT
Lung, Respiratory and Thoracic Cancer
COCOON Study: Enhanced dermatologic management reduces dermatologic adverse events with amivantamab plus lazertinib in patients with NSCLC harboring common EGFR mutations*
Central Nervous System Tumors
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
Neuro Oncol
Wen PY, Weller M, Lee EQ, Touat M, Khasraw M, Rahman R, Platten M, Lim M, Winkler F, Horbinski C, Verhaak RGW, Huang RY, Ahluwalia MS, Albert NL, Tonn JC, Schiff D, Barnholtz-Sloan JS, Ostrom Q, Aldape KD, Batchelor TT, Bindra RS, Chiocca EA, Cloughesy TF, DeGroot JF, French P, Galanis E, Galldiks N, Gilbert MR, Hegi ME, Lassman AB, Le Rhun E, Mehta MP, Mellinghoff IK, Minniti G, Roth P, Sanson M, Taphoorn MJB, von Deimling A, Weiss T, Wick W, Zadeh G, Reardon DA, Chang SM, Short SC, van den Bent MJ, Preusser M
doi: 10.1093/neuonc/noaf177
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Managing lorlatinib together: An overview and practical guide for patients by ALK-positive NSCLC patients and medical experts
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Pronsati N, Liu G, Bauer TM, Felip E, Goto Y, Green G, Grizzard M, Hamel M, Mazieres J, Mok T, Snow S, Solomon BJ, Stratmann J, Culver K
doi: 10.1016/j.lungcan.2025.108662
SPECIAL REPORT
Breast Cancer
Managing Side Effects in Breast Cancer Treatment
Lung, Respiratory and Thoracic Cancer
Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024
Cancer
Florez N, Patel S, Wakelee HA, Rotow J, Shum E, Sands J, Salgia R, Hirsch FR, Peters S, Sabari J, Husain H, Bazhenova L, Massarelli E, Backhus LM, Lee P, Herbst RS, Bestvina C, Higgins K, Desai A, Dietrich M, Keshava HB, Halmos B, Gandara DR, Riess JW, Velázquez AI, Sibley A, Shields M, Sen T, Kim ES
doi: 10.1002/cncr.70060
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Global advances and future directions in lung cancer care: expert consensus and strategic priorities
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
ESMO Open
Meyer ML, Peters S, Jänne PA, Mok TS, Bunn PA, Abdel Karim N, Altorki NK, Arrieta O, Bar J, Cappuzzo F, Carbone D, Dacic S, Diehn M, Dziadziuszko R, Felip E, Flores R, Florez N, Forde PM, Gainor JF, Gray JE, Gros L, Halmos B, Henschke CI, Herbst R, Heymach JV, Kelly K, Kris MG, Leighl NB, Mathias C, Marron TU, Mulshine JL, Naidoo J, Osarogiagbon R, Passaro A, Peled N, Planchard D, Politi K, Popat S, Pyenson B, Reckamp KL, Ren SH, Riely GJ, Rolfo C, Rudin CM, Sen T, Shields MD, Singh H, Skoulidis F, Solomon BJ, Stahel R, Stiles BM, Syrigos K, Yang JC, Yang PC, Wolf A, Wozniak AJ, Waqar SN, Wakelee H, Hirsch FR
doi: 10.1016/j.esmoop.2025.106034
Leukemia
2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia
Leukemia
Apperley JF, Milojkovic D, Cross NCP, Hjorth-Hansen H, Hochhaus A, Kantarjian H, Lipton JH, Malhotra H, Niederwieser D, Radich J, Rousselot P, Saussele S, Schiffer CA, Silver R, Soverini S, Stenke L, Turkina A, Casado LF, Castagnetti F, Cervantes F, Clark RE, Cortes J, Deininger M, Hughes TP, Janssen J, Jiang Q, Kim DW, Larson RA, Mahon FX, Mauro M, Mayer J, Nicolini FE, Pane F, Rea D, Richter J, Rosti G, Saglio G, Hehlmann R
doi: 10.1038/s41375-025-02664-w
Sarcoma
Management of multifocal and metastatic retroperitoneal sarcoma: an updated consensus approach from the transatlantic retroperitoneal sarcoma working group (TARPSWG)
Cancer Treat Rev
Fabbroni C, Johnston EW, Sanfilippo R, Strauss DC, Bonvalot S, Spalek M, Van Houdt WJ, Ford SJ, Lee KW, Salawu A, Swallow CJ, Bae S, Gyorki DE, Raut CP, Mullinax JE, Albertsmeier M, Cananzi F, Konieczkowski D, Grignol VP, Pennacchioli E, Solli P, Napolitano A, Blasi ED, Wilkinson M, Stacchiotti S, Tzanis D, Rutkowski P, Bouhadiba T, Schrage YM, Sherriff J, Wang J, Callegaro D, Farma JM, Fiore M, Gervais MK, Gladdy RA, Nessim C, Roland CL, Cranmer L, Lee TY, Patel S, von Mehren M, Wagner AJ, Sicklick J, Gronchi A, Tseng WW
doi: 10.1016/j.ctrv.2025.103086
Lung, Respiratory and Thoracic Cancer
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group
Lung Cancer
Brandão M, Prisciandaro E, Xenophontos E, Mariolo A, Sadeghi AH, Filippi AR, Levy A, Bandura A, Caramella C, Dickhoff C, de Margerie-Mellon C, Faivre-Finn C, Portik D, Sanchez-Lorente D, De Ruysscher D, Smit E, Gobbini E, Fadel E, Ruffini E, Olmetto E, Cortiula F, Bahce I, Houda I, Opitz I, Naidoo J, Edwards J, Remon J, Benitez JC, Trujillo JC, Derks J, Amrane K, Hartemink KJ, Stathopoulos K, Hendriks LEL, Iglesias M, Occhipinti M, Guckenberger M, Giaj Levra N, Girard N, Reguart N, Mercier O, Bironzo P, Hofman P, Petersen RH, De Angelis R, Abgral R, Terrisse S, Popat S, Pierret T, Blum TG, Ricardi U, Dionisi V, Berghmans T, Dingemans AC, European Organisation for Research, Treatment of Cancer EORTC Lung Cancer Group
doi: 10.1016/j.lungcan.2025.108798